The Impact of Bone Metastasis Location in the Clinical Outcome of Patients with Metastatic Renal Cell Carcinoma (mRCC): An Analysis from the Latin American Renal Cancer Group (LARCG)

Renal carcinoma
DOI: 10.26502/jcsct.5079092 Publication Date: 2020-10-24T09:11:31Z
ABSTRACT
Background: Tumor burden and metastatic disease sites are well-established prognostic factors in many malignancies, including Renal Cell Carcinoma (mRCC).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)